Nowadays, a greater number of men are treated with symptomatic benign prostate hypertrophy, which is called in short BPH. The principle treatment of BPH is TURP explained as the transurethral resection of the prostate. Whereas, in general, procedure is safe, patients need an epidural, spinal, or general anesthesia and more than a few days of hospital stay.
The potential mortality restricts the use of TURP in patients at high surgical risk. Possible complications include infection, prolonged catheterization, bleeding, and TURP syndrome or stricture formation. This exchange of risk for effectiveness is an ordinar tendency running through all possible treatments for BPH. That is why the newer modalities have been expected to provide alternatives to pharmacotherapy or alert waiting.
Acceptability of patients is large, if they are suggested a one-time method of treating lower urinary tract symptoms secondary to BPH and the method offers reduced risk. One of such methods is transurethral microwave thermotherapy or thermotherapy of the prostate called (TUMT) includes the placing of a specifically designed Foley-type catheter into the bladder and allows a microwave antenna being correctly positioned within the prostate fossa. Using microwaves to produce heat for devastation of hyperplasic prostate tissue, thermotherapy of the prostate is a potentially minimum invasive procedure characterized by the smallest morbidity and mortality.
The basic goal of microwave thermotherapy is to offer efficacious treatment with less risk for patient than that of TURP. Early results show brilliant symptomatic simplification in as little as one outpatient session using just local anesthesia even though the long-term follow-up data are not yet accessible. Founded on the current literature, TUMT actually is related with a lower surgical and anesthetic risk than TURP. But it is linked with less progress in urinary functioning.
Note that microwave thermotherapy is one of the numerous surgical therapies available for the treatment of the prostate. Clinical treatment and indications parameters for thermotherapy of the prostate are still evolving as technology advances and additional experience is gained. Below we summarize present knowledge of indications and effectiveness of microwave therapy of the prostate.
The problem which we talk about consists in the fact that BPH is one of the most widespread diseases of the male, and it is expected that one third of men older than 50 years enlarge symptoms of prostatism, and 30% of them will eventually demand surgery.
The prostate commonly is evaluated in medicine for its laterality and size, consistency and landmarks, and the presence or absence of modularity. The Indications for microwave thermotherapy are nearly alike to transurethral resection of the prostate. Indications involve people with moderate-to-severe disruptive or irritative voiding symptoms as well patients for whom medical therapy has failed, as people who choose not to be managed medically.
Though, most doctors agree that patients with mild-to-moderate symptoms should be treated with medical therapy or small interventions, reserving more perfect therapy for those with more cruel symptoms. Once a patient is presented for more perfect therapy, suspiciously consider the type of surgery. As the principle standard, TURP is suggested to most patients, but the potential advantages of microwave therapy over TURP involve the relief of minor urinary tract symptoms with an in-office procedure using the smallest anesthesia and a potentially rapid restoration.
Thermotherapy of the prostate is considered in patients who wish an outpatient setting rather than a hospital stay and for those people who are at an enlarged surgical or anesthetic risk.